Authors
Latest:
Using data analytics to effectively manage populationsAn active population health management program is key to improving performance, and it needs big data engagement analytics if it’s going to succeed.
Latest:
Fighting back against 340B criticismsIn this commentary, three pharmacy experts explain why they believe the 340B Drug Program is a needed safety net for safety net hospitals.
Latest:
Survey: Healthcare C-Suite Ready for Pop Health ManagementAt the recent Midas+ Annual Symposium, C-level healthcare executives were asked about their perspective on population health management. Here's what they said.
Latest:
The potential effects of the proposed payer mergersA deeper dive into the proposed payer mergers reveals how they could impact market dynamics.
Latest:
New Payment Model Improves Cancer Care at Oncology GroupCEO of a Pennsylvania-based oncology group shares how participating in a new value-based model is changing the care approach.
Latest:
Assess healthcare leadership's ability to handle a crisisIf a crisis were to suddenly arise for your organization, would your people be ready to handle it?
Latest:
Volume to value: A successful hospital's 5 best practicesPhoenix Children's Hospital's leadership team looked at how the foundational practices of accountable care could be implemented at the pediatric level. Here's what they found.
Latest:
Diverse health IT partnerships are critical to interoperabilityAs managed care leaders, better care for patients can be achieved through increased medical data exchange through diverse and collaborative organization involvement.
Latest:
Premium Content Preview | BYOD Trends in Healthcare: 2015 Survey Data RevealedA popular topic for hospitals right now is whether to allow employees to use their personal smartphones and tablets for staffcommunications and patient alerts. “Bring your own device” (BYOD) is a challenging issue because it encompasses so manyquestions related to an organization’s costs, security risks, IT availability, and the varying needs of different groups of staff.There is no one-size-fits all answer, and the landscape is changing rapidly as mobile strategies in healthcare mature.
Latest:
Pandemic Demands Highlight Resilience, Value of Physician AssistantsCOVID-19 has applied a type of pressure on the U.S. this year that none of us have experienced in our lifetimes. Like every other segment of healthcare professionals, certified physician assistants have been put to the test during 2020.
Latest:
Ten ways NPs reduce costs, improve qualityCindy Cooke, president of the American Association of Nurse Practitioners, shares 10 ways nurse practitioners reduce healthcare costs while improving quality.
Latest:
Assess healthcare leadership's ability to handle a crisisIf a crisis were to suddenly arise for your organization, would your people be ready to handle it?
Latest:
Put drug development to work for diabetic patientsAlthough the diabetes pipeline is not large, we continue to have progress in meeting the unmet needs of patients with diabetes.
Latest:
Mend fragmented payer-provider relations: 4 tipsPayers and providers have traditionally operated on opposite sides of the tracks with limited collaboration, resulting in a disjointed and complicated experience for patients when accessing care.
Latest:
The potential effects of the proposed payer mergersA deeper dive into the proposed payer mergers reveals how they could impact market dynamics.
Latest:
What should healthcare price transparency look like?Health policy experts generally agree that properly tailored transparency tools can help to hold down prices. What is not settled at this point is what transparency should look like.
Latest:
Telehealth reimbursement under the microscopeIn this commentary, attorney Nathaniel Lacktman shares why, in the era of payment reform, it is critical for health plans to provide telemedicine reimbursement.
Latest:
Why study international healthcare?Those who are in decision-making roles must study how other countries address healthcare financing and delivery so as to bring the best initiatives of the studied country to the healthcare systems they oversee.
Latest:
What should healthcare price transparency look like?Health policy experts generally agree that properly tailored transparency tools can help to hold down prices. What is not settled at this point is what transparency should look like.
Latest:
Four reasons payers need to embrace the digital economyConsumer and provider expectations have changed as a result of the digital economy. Here are four reasons why payers need to start migrating their businesses in that direction.
Latest:
Three tools for successful risk-based pharma negotiationsBiopharmaceutical manufacturers’ at-risk day is coming. Here’s how to prepare.
Latest:
Commercial payers: Don't leave money on the tableTo put more risk-based dollars in the bank, payers need to master a new level of gathering and reporting on not just claims data, but clinical data as well.
Latest:
Meaningful Use final rule: 4 Tips for hospitalsHospitals and physicians must be diligent in the implementation of their meaningful use business or strategic plan.
Latest:
CMS' mandatory bundled payment model: How to prepareThe Comprehensive Care for Joint Replacement (CCJR), has organizations’ leadership wondering how they will be able to perform in such a model. Here are some tips.
Latest:
Five attributes of health plans poised to winToday’s value-focused economy was a primary discussion point at a recent roundtable of health plan CEOs. The discussion led to five essential attributes that organizations must embrace to thrive.
Latest:
Super clinically integrated networks: 8 components to considerClinically Integrated Networks (CINs) are evolving quickly across the country in response to changing reimbursement trends and the move to value-based payments.
Latest:
Super clinically integrated networks: 8 components to considerClinically Integrated Networks (CINs) are evolving quickly across the country in response to changing reimbursement trends and the move to value-based payments.
Latest:
Will biosimilars deliver on expectations?This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.
